NCT00670683View on ClinicalTrials.gov

Observational Study of Patients With Diabetes Using Levemir® FlexPen®

CompletedOBSERVATIONAL

Enrollment

797

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

Trial Locations (1)

602-739

Pusan

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY

NCT00670683 - Observational Study of Patients With Diabetes Using Levemir® FlexPen® | Biotech Hunter | Biotech Hunter